Russian developer of diagnostic kits and test systems for patients is looking for foreign distributors

A Russian company from Novosibirsk develops and produces medical test systems for the diagnosis of human diseases. The product range includes test systems, enzyme immunoassay, multicomplex diagnostics, PCR tests. The company is interested in finding reliable partners from the medical field to conclude a long-term distribution services agreement.
The company from Novosibirsk is engaged in innovative developments in the field of medicine. For several years of its operation, the company has become a leader in Russia in the production of test systems for detecting diseases in patients. The company is a developer of innovative multiplex kits for the early diagnosis of various diseases. The company develops kits for enzyme immunoassay, multicomplex diagnosis of PCR tests. In addition, the company is a leading distributor of a number of Russian and foreign manufacturers of test systems for medicine. The enzyme immunoassay test system is a method of laboratory diagnostics that allows medical institutions to identify substances of a protein nature (including enzymes, viruses, bacterial fragments, and other components of biological fluids). With the help of this test system, the following types of viruses are identified: diagnosis of HIV infection, chlamydia infection, syphilis, gonorrhea, candidiasis, herpes infection, etc. The developed test system for multicomplex diagnostics (immunochips) is a comprehensive diagnosis of infections in patients. This is a new direction of enzyme immunoassay in which special protein matrices of immunochips are used, allowing to simultaneously determine many different analyzes in the test sample. Immunochips are designed for simultaneous detection of antibodies and antigens to pathogens of various types of infections in human serum and plasma: hepatitis C, B, measles, rubella, herpes. In addition, in recent years, the company has been actively developing solutions for test systems and expert diagnostics for the timely detection of Covid-19. The company's production is located near research and production complexes and other innovation centers. The entire technological cycle of production and quality control of medical test systems is carried out on the production base of the company. Highly qualified specialists work in the production and modern equipment is used. The Russian company is interested in finding reliable medical partners for concluding distribution services agreements. The company is ready to produce and supply test systems to a potential partner. All test systems comply with medical standards and certification. All delivered products are sealed in a special hermetic packaging for complete sterility. In addition, the company is ready to conduct research and develop a multiplex kit (immunochip) based on the partner's technical specification, which allows simultaneous determination of up to eight or more analyzes in one sample, as well as organize mass production of the necessary immunochip.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought: 
Type: SMEs, large companies, companies that distribute medical products, companies that provide medical laboratories, hospitals. Role: in accordance with this distribution services agreement, the foreign partner will have to distribute Russian products on its foreign market. The products should be distributed among the portfolio of potential customers from the medical field.
Stage of Development: 
Already on the market
IPR Status: 
Secret Know-how
External code: